How to File a claim for Celebrex injury

Written by Jefferson Highway, General Counsel

There is mounting evidence to suggest that Celebrex (aka celecoxib) is linked to an increased risk of blood clots, heart attacks and strokes. Celebrex is one ofrepparttar newer anti arthritic drugs called COX-2 inhibitors that were launched inrepparttar 105603 1990s, and is marketed by Pharmacia Corporation and Pfizer Inc. The drug is prescribed for osteoarthritis, adult rheumatoid arthritis, and menstrual cramps. The FDA is currently taking independent advice on whether these COX-2 inhibitors, and Celebrex in particular, are safe to remain on sale. Current studies "strongly suggest"repparttar 105604 COX-2 inhibitors increaserepparttar 105605 risk of cardiovascular problems, says Dr. Ned Braunstein, senior director of Merck Research Laboratories. A related study fromrepparttar 105606 Cleveland Clinic, published inrepparttar 105607 Journal ofrepparttar 105608 American Medical Association suggested thatrepparttar 105609 risk of cardiovascular problems (including but not limited to heart attacks, chest pains, stroke, death and blood clots), was over twice as high inrepparttar 105610 rofecoxib sample than inrepparttar 105611 control group - a significant find given thatrepparttar 105612 analysis was based on more than 8,000 patients. In yet another study of over 42,000 participants, 0.52% of patients taking a placebo pill had a heart attack each year compared to 0.74% for patients taking rofecoxib and 0.80% for those taking celecoxib. It's big business too -repparttar 105613 drug will do over $6 billion this year alone.


Written by

Cont'd on page 2 ==> © 2005
Terms of Use